Pediatric Myelodysplastic Syndromes

被引:5
|
作者
Patel, Sanjay S. [1 ]
机构
[1] Weill Cornell Med Coll, NewYork Presbyterian Hosp, Div Hematopathol, 525 East 68th St,Starr 711A, New York, NY 10065 USA
关键词
Myelodysplastic syndrome; MDS; Dysplasia; Inherited bone marrow failure; Stem cell transplant; JUVENILE MYELOMONOCYTIC LEUKEMIA; STEM-CELL TRANSPLANTATION; 4-COLOR FLOW-CYTOMETRY; REFRACTORY CYTOPENIA; APLASTIC-ANEMIA; MYELOPROLIFERATIVE DISORDERS; FAMILIAL THROMBOCYTOPENIA; CLINICAL CHARACTERISTICS; CHILDHOOD; CHILDREN;
D O I
10.1016/j.cll.2021.03.015
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
incidentally on routine laboratory investigation, or during the work-up for a suspected inherited bone marrow failure (IBMF) syndrome.1-9 More frequently, patients present with symptoms related to occult cytopenias, including fatigue, fever, infection, and/ or bleeding.9 In contrast with adults, pediatric patients with MDS more often present with bicytopenias, rather than isolated anemia. Given the association with IBMF syndromes in many cases, physical examination findings may be particularly informative, and may reveal skeletal, cutaneous, genitourinary, cardiovascular, and/or gastrointestinal anomalies. The combination of cytopenias and a hypocellular bone marrow is alone nonspecific, and therefore the following differential diagnostic considerations warrant exclusion: vitamin and/or mineral deficiencies and zinc toxicity10, viral infections; toxin or drug exposures11; autoimmune and other rheumatologic disorders, such as juvenile rheumatoid arthritis; mitochondrial disorders (eg, Pearson syndrome); various metabolic disorders; inherited anemias; and IBMF syndromes.
引用
收藏
页码:517 / 528
页数:12
相关论文
共 50 条
  • [31] An overview of myelodysplastic syndromes
    Pontrelli, Gina
    Loscalzo, Carina
    L'Eplattenier, Mark
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2023, 36 (06): : 17 - 21
  • [32] Transplants in Myelodysplastic Syndromes
    Wetzko, Katrin
    Platzbecker, Uwe
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 28 (06) : 1011 - +
  • [33] Myelodysplastic and myeloproliferative disorders of childhood
    Hasle, Henrik
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 598 - 604
  • [34] Update on cytogenetic and molecular changes in myelodysplastic syndromes
    Schlegelberger, Brigitte
    Goehring, Gudrun
    Thol, Felicitas
    Heuser, Michael
    LEUKEMIA & LYMPHOMA, 2012, 53 (04) : 525 - 536
  • [35] World Health Organization Classification of Myelodysplastic Syndromes
    Czader, Magdalena
    Orazi, Attilio
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (22) : 3149 - 3162
  • [36] Update on the pharmacotherapy for myelodysplastic syndromes
    Duong, Vu H.
    Komrokji, Rami S.
    List, Alan F.
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (13) : 1811 - 1825
  • [37] Myelodysplastic Syndromes: A New Decade
    Volpe, Virginia O.
    Garcia-Manero, Guillermo
    Komrokji, Rami S.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (01) : 1 - 16
  • [38] Getting personal with myelodysplastic syndromes: is now the right time?
    Chokr, Nora
    Pine, Alexander B.
    Bewersdorf, Jan Philipp
    Shallis, Rory M.
    Stahl, Maximilian
    Zeidan, Amer M.
    EXPERT REVIEW OF HEMATOLOGY, 2019, 12 (04) : 215 - 224
  • [39] Therapeutic approaches in myelofibrosis and myelodysplastic/myeloproliferative overlap syndromes
    Sochacki, Andrew L.
    Fischer, Melissa A.
    Savona, Michael R.
    ONCOTARGETS AND THERAPY, 2016, 9 : 2273 - 2286
  • [40] Myelodysplastic Syndromes: Updates and Nuances
    Dao, Kim-Hien T.
    MEDICAL CLINICS OF NORTH AMERICA, 2017, 101 (02) : 333 - +